These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 31270465)

  • 1. Beneficial visual outcome of vitrectomy and delamination surgery for tractional complications of diabetic retinopathy in a cohort of black patients.
    Ho J; Williamson TH; Wong RS; Laidlaw DAH
    Eye (Lond); 2019 Dec; 33(12):1884-1889. PubMed ID: 31270465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Black patients sustain vision loss while White and South Asian patients gain vision following delamination or segmentation surgery for tractional complications associated with proliferative diabetic retinopathy.
    Mastropasqua R; Luo YH; Cheah YS; Egan C; Lewis JJ; da Cruz L
    Eye (Lond); 2017 Oct; 31(10):1468-1474. PubMed ID: 28574495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical and visual outcome following 20-gauge vitrectomy in proliferative diabetic retinopathy over a 10-year period, evidence for change in practice.
    Gupta B; Wong R; Sivaprasad S; Williamson TH
    Eye (Lond); 2012 Apr; 26(4):576-82. PubMed ID: 22241020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Royal College of Ophthalmologists' National Ophthalmology Database Study of Vitreoretinal Surgery: Report 6, Diabetic Vitrectomy.
    Jackson TL; Johnston RL; Donachie PH; Williamson TH; Sparrow JM; Steel DH
    JAMA Ophthalmol; 2016 Jan; 134(1):79-85; quiz 120. PubMed ID: 26584210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Intravitreal Ranibizumab on the Surgical Outcome for Diabetic Retinopathy With Tractional Retinal Detachment.
    Dong F; Yu C; Ding H; Shen L; Lou D
    Medicine (Baltimore); 2016 Feb; 95(8):e2731. PubMed ID: 26937902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcomes of sutureless 25-G+ pars-plana vitrectomy for the management of diabetic tractional retinal detachment.
    Mikhail M; Ali-Ridha A; Chorfi S; Kapusta MA
    Graefes Arch Clin Exp Ophthalmol; 2017 Feb; 255(2):255-261. PubMed ID: 27480177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term visual and retinopathy outcomes in a predominately type 2 diabetic patient population undergoing early vitrectomy and endolaser for severe vitreous haemorrhage.
    Ratnarajan G; Mellington F; Saldanha M; de Silva SR; Benjamin L
    Eye (Lond); 2011 Jun; 25(6):704-8; quiz 709. PubMed ID: 21494282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravitreal Conbercept Injection as an Adjuvant in Vitrectomy with Silicone Oil Infusion for Severe Proliferative Diabetic Retinopathy.
    Gao S; Lin Z; Chen Y; Xu J; Zhang Q; Chen J; Shen X
    J Ocul Pharmacol Ther; 2020 Jun; 36(5):304-310. PubMed ID: 32186940
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of Tamponade in Vitrectomy for Proliferative Diabetic Retinopathy with Vitreous Hemorrhage.
    Balakrishnan D; Jain B; Nayaka A; Rani PK; Mukundaprasad V; Jalali S
    Semin Ophthalmol; 2017; 32(4):488-491. PubMed ID: 27128601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors of revitrectomy for complications in eyes with proliferative diabetic retinopathy: a retrospective multicentre study.
    Takayama K; Someya H; Yokoyama H; Kimura T; Takamura Y; Morioka M; Sameshima S; Ueda T; Ogata N; Kitano S; Tashiro M; Sugimoto M; Kondo M; Sakamoto T; Takeuchi M
    Acta Ophthalmol; 2020 Jun; 98(4):e434-e439. PubMed ID: 31674137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical outcomes of vitrectomy surgery for proliferative diabetic retinopathy in patients with abnormal renal function.
    Larrañaga-Fragoso P; Laviers H; McKechnie C; Zambarakji H
    Graefes Arch Clin Exp Ophthalmol; 2020 Jan; 258(1):63-70. PubMed ID: 31758258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intra-silicone oil injection of methotrexate at the end of vitrectomy for advanced proliferative diabetic retinopathy.
    Ghasemi Falavarjani K; Modarres M; Hadavandkhani A; Karimi Moghaddam A
    Eye (Lond); 2015 Sep; 29(9):1199-203. PubMed ID: 26160528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phacoemulsification and foldable intraocular lens implantation combined with vitrectomy and silicone oil tamponade for severe proliferative diabetic retinopathy.
    Kim SH; Chung JW; Chung H; Yu HG
    J Cataract Refract Surg; 2004 Aug; 30(8):1721-6. PubMed ID: 15313297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors and Outcomes of Vitrectomy and Silicone Oil Injection in Advanced Diabetic Retinopathy.
    Ramezani A; Ahmadieh H; Rozegar A; Soheilian M; Entezari M; Moradian S; Dehghan MH; Nikkhah H; Yaseri M
    Korean J Ophthalmol; 2017 Jun; 31(3):217-229. PubMed ID: 28534343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Combined pharmacosurgery as treatment for diabetic macular edema: core pars plana vitrectomy and intravitreal injection of bevacizumab and triamcinolone].
    Naser H; Koss MJ; Singh P; Koch F
    Klin Monbl Augenheilkd; 2011 Oct; 228(10):910-4. PubMed ID: 21997827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BIMANUAL MICROINCISION VITREOUS SURGERY FOR SEVERE PROLIFERATIVE DIABETIC RETINOPATHY: OUTCOME IN MORE THAN 300 EYES.
    Shroff CM; Gupta C; Shroff D; Atri N; Gupta P; Dutta R
    Retina; 2018 Sep; 38 Suppl 1():S134-S145. PubMed ID: 29406470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transconjunctival 25-gauge sutureless vitrectomy and silicone oil injection in diabetic tractional retinal detachment.
    Altan T; Acar N; Kapran Z; Unver YB; Ozdogan S
    Retina; 2008 Oct; 28(9):1201-6. PubMed ID: 18728620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SILICONE OIL VERSUS PERFLUOROPROPANE GAS TAMPONADE DURING VITRECTOMY FOR TRACTIONAL RETINAL DETACHMENT OR FIBROUS PROLIFERATION: A Randomized Clinical Trial.
    Rush RB; Del Valle Penella A; Reinauer RM; Rush SW; Bastar PG
    Retina; 2021 Jul; 41(7):1407-1415. PubMed ID: 33252584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influencing factors of low vision 2 years after vitrectomy for proliferative diabetic retinopathy: an observational study.
    Wang S; Liu Y; Du Y; Bao H; Zhu J; Liu X
    BMC Ophthalmol; 2023 Jul; 23(1):309. PubMed ID: 37430223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of 23-gauge and 20-gauge vitrectomy for proliferative sickle cell retinopathy - clinical outcomes and surgical management.
    Ho J; Grabowska A; Ugarte M; Muqit MM
    Eye (Lond); 2018 Sep; 32(9):1449-1454. PubMed ID: 29786087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.